News from AGA

To my fellow AGA Members, I’m not the first to tell you that real progress in the diagnosis, treatment, and cure of digestive disease is at risk. Research funding from traditional sources, like the National Institutes of Health, continues to shrink. We can expect even greater cuts on the horizon.

GI investigators in the early stages of their careers are particularly hard hit. They are finding it much more difficult to secure needed federal funding. As a result, many of these investigators are walking away from GI research frustrated by a lack of support.

It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.

You know that research has revolutionized the care of many digestive disease patients. These patients, as well as everyone in the GI field clinicians and researchers alike, have benefited from the discoveries of passionate investigators, past and present.

This is where you can help.

New treatments and devices are the result of years of research. The AGA Research Foundation grants are critical to continuing the GI pipeline. The AGA research awards program helps researchers take new directions and discover new treatments to better patient care.

Help us fund more researchers by supporting the AGA Research Foundation with a year-end donation. Your donation will support young investigators’ research careers and help assure research is continued.

Be gracious, generous and giving to the future of the GI specialty this holiday season. There are three easy ways to give:

Make a tax-deductible donation online at www. foundation.gastro.org. 

Send a donation through the mail to: 

AGA Research Foundation 

4930 Del Ray Avenue 

Bethesda, MD 20814 

Or donate over the phone by calling (301) 222-4002. All gifts are tax-deductible to the fullest extent of US law. Join us!

Dr. Camilleri is AGA Research Foundation Chair and Past AGA Institute President. He is a consultant in the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

To my fellow AGA Members, I’m not the first to tell you that real progress in the diagnosis, treatment, and cure of digestive disease is at risk. Research funding from traditional sources, like the National Institutes of Health, continues to shrink. We can expect even greater cuts on the horizon.

GI investigators in the early stages of their careers are particularly hard hit. They are finding it much more difficult to secure needed federal funding. As a result, many of these investigators are walking away from GI research frustrated by a lack of support.

It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.

You know that research has revolutionized the care of many digestive disease patients. These patients, as well as everyone in the GI field clinicians and researchers alike, have benefited from the discoveries of passionate investigators, past and present.

This is where you can help.

New treatments and devices are the result of years of research. The AGA Research Foundation grants are critical to continuing the GI pipeline. The AGA research awards program helps researchers take new directions and discover new treatments to better patient care.

Help us fund more researchers by supporting the AGA Research Foundation with a year-end donation. Your donation will support young investigators’ research careers and help assure research is continued.

Be gracious, generous and giving to the future of the GI specialty this holiday season. There are three easy ways to give:

Make a tax-deductible donation online at www. foundation.gastro.org. 

Send a donation through the mail to: 

AGA Research Foundation 

4930 Del Ray Avenue 

Bethesda, MD 20814 

Or donate over the phone by calling (301) 222-4002. All gifts are tax-deductible to the fullest extent of US law. Join us!

Dr. Camilleri is AGA Research Foundation Chair and Past AGA Institute President. He is a consultant in the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

To my fellow AGA Members, I’m not the first to tell you that real progress in the diagnosis, treatment, and cure of digestive disease is at risk. Research funding from traditional sources, like the National Institutes of Health, continues to shrink. We can expect even greater cuts on the horizon.

GI investigators in the early stages of their careers are particularly hard hit. They are finding it much more difficult to secure needed federal funding. As a result, many of these investigators are walking away from GI research frustrated by a lack of support.

It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.

You know that research has revolutionized the care of many digestive disease patients. These patients, as well as everyone in the GI field clinicians and researchers alike, have benefited from the discoveries of passionate investigators, past and present.

This is where you can help.

New treatments and devices are the result of years of research. The AGA Research Foundation grants are critical to continuing the GI pipeline. The AGA research awards program helps researchers take new directions and discover new treatments to better patient care.

Help us fund more researchers by supporting the AGA Research Foundation with a year-end donation. Your donation will support young investigators’ research careers and help assure research is continued.

Be gracious, generous and giving to the future of the GI specialty this holiday season. There are three easy ways to give:

Make a tax-deductible donation online at www. foundation.gastro.org. 

Send a donation through the mail to: 

AGA Research Foundation 

4930 Del Ray Avenue 

Bethesda, MD 20814 

Or donate over the phone by calling (301) 222-4002. All gifts are tax-deductible to the fullest extent of US law. Join us!

Dr. Camilleri is AGA Research Foundation Chair and Past AGA Institute President. He is a consultant in the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Did you miss out on the AGA Postgraduate Course this year? We have you covered with AGA PG Course OnDemand, a complete capture of the 2024 AGA Postgraduate Course, The Latest from the Greatest.

Visit agau.gastro.org to purchase today for flexible, on-the-go access to the latest clinical advances in the GI field.

• Unparalleled access: Choose when and where you dive into content with convenient access from any computer or mobile device.
• Incredible faculty: Learn from renowned experts who will offer their perspectives on cutting-edge research and clinical guidance.
• Tangible strategies: Expert and early career faculty will guide you through challenging patient cases and provide strategies you can easily implement upon your return to the office.
• Efficient learning: Content is organized by category: GI oncology, neurogastroenterology & motility, obesity, advanced endoscopy, and liver.
• Continuing education: With CME testing integrated directly into each session, you can easily earn up to 16 CME and MOC credits through December 31, 2024.

Did you miss out on the AGA Postgraduate Course this year? We have you covered with AGA PG Course OnDemand, a complete capture of the 2024 AGA Postgraduate Course, The Latest from the Greatest.

Visit agau.gastro.org to purchase today for flexible, on-the-go access to the latest clinical advances in the GI field.

• Unparalleled access: Choose when and where you dive into content with convenient access from any computer or mobile device.
• Incredible faculty: Learn from renowned experts who will offer their perspectives on cutting-edge research and clinical guidance.
• Tangible strategies: Expert and early career faculty will guide you through challenging patient cases and provide strategies you can easily implement upon your return to the office.
• Efficient learning: Content is organized by category: GI oncology, neurogastroenterology & motility, obesity, advanced endoscopy, and liver.
• Continuing education: With CME testing integrated directly into each session, you can easily earn up to 16 CME and MOC credits through December 31, 2024.

Did you miss out on the AGA Postgraduate Course this year? We have you covered with AGA PG Course OnDemand, a complete capture of the 2024 AGA Postgraduate Course, The Latest from the Greatest.

Visit agau.gastro.org to purchase today for flexible, on-the-go access to the latest clinical advances in the GI field.

• Unparalleled access: Choose when and where you dive into content with convenient access from any computer or mobile device.
• Incredible faculty: Learn from renowned experts who will offer their perspectives on cutting-edge research and clinical guidance.
• Tangible strategies: Expert and early career faculty will guide you through challenging patient cases and provide strategies you can easily implement upon your return to the office.
• Efficient learning: Content is organized by category: GI oncology, neurogastroenterology & motility, obesity, advanced endoscopy, and liver.
• Continuing education: With CME testing integrated directly into each session, you can easily earn up to 16 CME and MOC credits through December 31, 2024.

It’s critical to bring the voice of gastroenterology to Capitol Hill to make a real difference in legislation that affects patient care. That’s why we gathered our leaders from across the United States in Washington, DC, to meet with congressional offices during our annual Advocacy Day.

GIs from California to Massachusetts and many states in between met with House and Senate offices to educate members of Congress and their staff about the most critical policy issues impacting you and your patients. In total, 28 states were represented and we attended more than 100 meetings in 64 different districts, which was a mix of both Republican and Democratic offices.

University of Miami

For the second year in a row, we were fortunate to be joined by GI patient advocates as well, who shared personal stories about the challenges they encountered in the health care system, and the negative effects to their well-being and quality of life because of red tape caused by prior authorization and step therapy.

The in-person advocacy of our members and patient advocates makes a difference. In one of AGA President Dr. Maria Abreu’s meetings, the congressional staffer remembered that he met with her, Dr. Mel Wilcox, and a patient advocate during 2023’s Advocacy Day and recounted the impact of their conversation about delays to timely access to care for inflammatory bowel disease medication.

Numerous GIs had similar experiences on Advocacy Day and recounted the benefits of being able to walk into House and Senate offices and educate congressional staff on the issues they’re experiencing in their clinic or lab.

Being able to start these conversations about health care and GI and build these relationships showcases the value of Advocacy Day, and demonstrates how AGA works with members to make it easy to advocate for the issues important to them. We were able to have a full day of constructive meetings with lawmakers and their staff thanks to members and patient advocates. Thank you for being engaged and using your voices to protect GI patient care!






 

It’s critical to bring the voice of gastroenterology to Capitol Hill to make a real difference in legislation that affects patient care. That’s why we gathered our leaders from across the United States in Washington, DC, to meet with congressional offices during our annual Advocacy Day.

GIs from California to Massachusetts and many states in between met with House and Senate offices to educate members of Congress and their staff about the most critical policy issues impacting you and your patients. In total, 28 states were represented and we attended more than 100 meetings in 64 different districts, which was a mix of both Republican and Democratic offices.

University of Miami

For the second year in a row, we were fortunate to be joined by GI patient advocates as well, who shared personal stories about the challenges they encountered in the health care system, and the negative effects to their well-being and quality of life because of red tape caused by prior authorization and step therapy.

The in-person advocacy of our members and patient advocates makes a difference. In one of AGA President Dr. Maria Abreu’s meetings, the congressional staffer remembered that he met with her, Dr. Mel Wilcox, and a patient advocate during 2023’s Advocacy Day and recounted the impact of their conversation about delays to timely access to care for inflammatory bowel disease medication.

Numerous GIs had similar experiences on Advocacy Day and recounted the benefits of being able to walk into House and Senate offices and educate congressional staff on the issues they’re experiencing in their clinic or lab.

Being able to start these conversations about health care and GI and build these relationships showcases the value of Advocacy Day, and demonstrates how AGA works with members to make it easy to advocate for the issues important to them. We were able to have a full day of constructive meetings with lawmakers and their staff thanks to members and patient advocates. Thank you for being engaged and using your voices to protect GI patient care!






 

It’s critical to bring the voice of gastroenterology to Capitol Hill to make a real difference in legislation that affects patient care. That’s why we gathered our leaders from across the United States in Washington, DC, to meet with congressional offices during our annual Advocacy Day.

GIs from California to Massachusetts and many states in between met with House and Senate offices to educate members of Congress and their staff about the most critical policy issues impacting you and your patients. In total, 28 states were represented and we attended more than 100 meetings in 64 different districts, which was a mix of both Republican and Democratic offices.

University of Miami

For the second year in a row, we were fortunate to be joined by GI patient advocates as well, who shared personal stories about the challenges they encountered in the health care system, and the negative effects to their well-being and quality of life because of red tape caused by prior authorization and step therapy.

The in-person advocacy of our members and patient advocates makes a difference. In one of AGA President Dr. Maria Abreu’s meetings, the congressional staffer remembered that he met with her, Dr. Mel Wilcox, and a patient advocate during 2023’s Advocacy Day and recounted the impact of their conversation about delays to timely access to care for inflammatory bowel disease medication.

Numerous GIs had similar experiences on Advocacy Day and recounted the benefits of being able to walk into House and Senate offices and educate congressional staff on the issues they’re experiencing in their clinic or lab.

Being able to start these conversations about health care and GI and build these relationships showcases the value of Advocacy Day, and demonstrates how AGA works with members to make it easy to advocate for the issues important to them. We were able to have a full day of constructive meetings with lawmakers and their staff thanks to members and patient advocates. Thank you for being engaged and using your voices to protect GI patient care!






 

What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.

How will we get there? New treatments and devices are the result of years of research.

To help make this dream a reality, AGA — through the AGA Research Foundation — has made a commitment to support investigators in GI and hepatology with its Research Awards Program.

With the help of AGA members, like you, the AGA Research Foundation can provide research funding to highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.

To our AGA Research Foundation donors, we sincerely thank you for your gifts.

We invite the GI community to join others in supporting and helping spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow.

Make your tax-deductible gift today at www.gastro.org/donateonline.






 

What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.

How will we get there? New treatments and devices are the result of years of research.

To help make this dream a reality, AGA — through the AGA Research Foundation — has made a commitment to support investigators in GI and hepatology with its Research Awards Program.

With the help of AGA members, like you, the AGA Research Foundation can provide research funding to highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.

To our AGA Research Foundation donors, we sincerely thank you for your gifts.

We invite the GI community to join others in supporting and helping spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow.

Make your tax-deductible gift today at www.gastro.org/donateonline.






 

What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.

How will we get there? New treatments and devices are the result of years of research.

To help make this dream a reality, AGA — through the AGA Research Foundation — has made a commitment to support investigators in GI and hepatology with its Research Awards Program.

With the help of AGA members, like you, the AGA Research Foundation can provide research funding to highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.

To our AGA Research Foundation donors, we sincerely thank you for your gifts.

We invite the GI community to join others in supporting and helping spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow.

Make your tax-deductible gift today at www.gastro.org/donateonline.






 

For our next installment of the Gastro Journal Club, we are honored to host Professor Willemijn de Klaver, MD, PhD, and Professor Evelien Dekker, PhD, from Amsterdam University Medical Centers in the Netherlands. They are joined by fellows from the Icahn School of Medicine at Mount Sinai in New York City for a discussion of the article “Risk of Cancers Proximal to the Colon in Fecal Immunochemical Test Positive Screenees in a Colorectal Cancer Screening Program,” published in the September 2024 issue of Gastroenterology .

Visit our YouTube Channel (youtube.com/@AmerGastroAssn) to watch the session.

The Gastro Journal Club is by and for fellows and residents. During these sessions, fellows and residents have the opportunity to ask authors questions about their recently published work in Gastroenterology. If you are interested in arranging a Gastro Journal Club session at your institution, please contact mpogachar@gastro.org.






 

For our next installment of the Gastro Journal Club, we are honored to host Professor Willemijn de Klaver, MD, PhD, and Professor Evelien Dekker, PhD, from Amsterdam University Medical Centers in the Netherlands. They are joined by fellows from the Icahn School of Medicine at Mount Sinai in New York City for a discussion of the article “Risk of Cancers Proximal to the Colon in Fecal Immunochemical Test Positive Screenees in a Colorectal Cancer Screening Program,” published in the September 2024 issue of Gastroenterology .

Visit our YouTube Channel (youtube.com/@AmerGastroAssn) to watch the session.

The Gastro Journal Club is by and for fellows and residents. During these sessions, fellows and residents have the opportunity to ask authors questions about their recently published work in Gastroenterology. If you are interested in arranging a Gastro Journal Club session at your institution, please contact mpogachar@gastro.org.






 

For our next installment of the Gastro Journal Club, we are honored to host Professor Willemijn de Klaver, MD, PhD, and Professor Evelien Dekker, PhD, from Amsterdam University Medical Centers in the Netherlands. They are joined by fellows from the Icahn School of Medicine at Mount Sinai in New York City for a discussion of the article “Risk of Cancers Proximal to the Colon in Fecal Immunochemical Test Positive Screenees in a Colorectal Cancer Screening Program,” published in the September 2024 issue of Gastroenterology .

Visit our YouTube Channel (youtube.com/@AmerGastroAssn) to watch the session.

The Gastro Journal Club is by and for fellows and residents. During these sessions, fellows and residents have the opportunity to ask authors questions about their recently published work in Gastroenterology. If you are interested in arranging a Gastro Journal Club session at your institution, please contact mpogachar@gastro.org.






 

The 2025 Crohn’s & Colitis Congress^®, a partnership of the Crohn’s & Colitis Foundation and AGA, is now accepting original inflammatory bowel disease (IBD)-research abstract submissions through Oct. 16. Abstracts are free to submit and may be selected for in-person lectures or poster presentations. Accepted abstracts will also be co-published in AGA’s Gastroenterology (https://www.gastrojournal.org/) and the Crohn’s & Colitis Foundation’s Inflammatory Bowel Diseases (https://academic.oup.com/ibdjournal).

Be sure to review the abstract submission guidelines and submit by 9 p.m. EDT, Wednesday, Oct. 16.

Presenting authors will receive notification of acceptance on Monday, Dec. 9.

The Crohn’s & Colitis Congress will take place Feb. 6-8, 2025, in San Francisco, California. It brings together the community of multidisciplinary experts and colleagues to revolutionize prevention, care and outcomes for IBD patients.

Learn alongside your colleagues and discover how to provide the absolute best care to those suffering with Crohn’s disease and ulcerative colitis.

The 2025 Crohn’s & Colitis Congress^®, a partnership of the Crohn’s & Colitis Foundation and AGA, is now accepting original inflammatory bowel disease (IBD)-research abstract submissions through Oct. 16. Abstracts are free to submit and may be selected for in-person lectures or poster presentations. Accepted abstracts will also be co-published in AGA’s Gastroenterology (https://www.gastrojournal.org/) and the Crohn’s & Colitis Foundation’s Inflammatory Bowel Diseases (https://academic.oup.com/ibdjournal).

Be sure to review the abstract submission guidelines and submit by 9 p.m. EDT, Wednesday, Oct. 16.

Presenting authors will receive notification of acceptance on Monday, Dec. 9.

The Crohn’s & Colitis Congress will take place Feb. 6-8, 2025, in San Francisco, California. It brings together the community of multidisciplinary experts and colleagues to revolutionize prevention, care and outcomes for IBD patients.

Learn alongside your colleagues and discover how to provide the absolute best care to those suffering with Crohn’s disease and ulcerative colitis.

The 2025 Crohn’s & Colitis Congress^®, a partnership of the Crohn’s & Colitis Foundation and AGA, is now accepting original inflammatory bowel disease (IBD)-research abstract submissions through Oct. 16. Abstracts are free to submit and may be selected for in-person lectures or poster presentations. Accepted abstracts will also be co-published in AGA’s Gastroenterology (https://www.gastrojournal.org/) and the Crohn’s & Colitis Foundation’s Inflammatory Bowel Diseases (https://academic.oup.com/ibdjournal).

Be sure to review the abstract submission guidelines and submit by 9 p.m. EDT, Wednesday, Oct. 16.

Presenting authors will receive notification of acceptance on Monday, Dec. 9.

The Crohn’s & Colitis Congress will take place Feb. 6-8, 2025, in San Francisco, California. It brings together the community of multidisciplinary experts and colleagues to revolutionize prevention, care and outcomes for IBD patients.

Learn alongside your colleagues and discover how to provide the absolute best care to those suffering with Crohn’s disease and ulcerative colitis.

The AGA editorial fellowship program, currently in its seventh year, selects several outstanding individuals who are interested in scientific publishing to take part in the year-long program. We are excited to announce the 2024-25 participants, who will gain hands-on experience and mentorship working closely with the editors and staff at the AGA journals over the next year.

The 10 editorial fellows (2 per journal) will learn about the entire editorial process, from manuscript submission to peer review to acceptance. They will participate in discussions and conferences with the boards of editors, assist with manuscript review, and help disseminate articles via their social media platforms.

AGA

Clinical Gastroenterology and Hepatology

Robyn Jordan, MD, MPH

Johns Hopkins Hospital, Baltimore | USA

Daryl Ramai, MD, MPH, MSc

Brigham and Women’s Hospital, Boston | USA
 

Cellular and Molecular Gastroenterology and Hepatology

Kole H. Buckley, PhD

University of Pennsylvania Perelman School of Medicine, Philadelphia | USA

Lin Y. Hung, PhD

New York University | USA
 

Gastroenterology

Corey J. Ketchem, MD

University of Pennsylvania, Philadelphia | USA

Rishad Khan, MD

University of Toronto | Canada
 

Gastro Hep Advances

Sasha Kapil, MD

UT Southwestern Medical Center, Dallas | USA

June Tome, MD

Mayo Clinic, Rochester, Minnesota | USA
 

Techniques and Innovations in Gastrointestinal Endoscopy

Thomas Enke, MD

University of Colorado, Aurora | USA

Sami Elamin, MD

Harvard, Beth Israel Deaconess Medical Center, Boston | USA

The AGA editorial fellowship program, currently in its seventh year, selects several outstanding individuals who are interested in scientific publishing to take part in the year-long program. We are excited to announce the 2024-25 participants, who will gain hands-on experience and mentorship working closely with the editors and staff at the AGA journals over the next year.

The 10 editorial fellows (2 per journal) will learn about the entire editorial process, from manuscript submission to peer review to acceptance. They will participate in discussions and conferences with the boards of editors, assist with manuscript review, and help disseminate articles via their social media platforms.

AGA

Clinical Gastroenterology and Hepatology

Robyn Jordan, MD, MPH

Johns Hopkins Hospital, Baltimore | USA

Daryl Ramai, MD, MPH, MSc

Brigham and Women’s Hospital, Boston | USA
 

Cellular and Molecular Gastroenterology and Hepatology

Kole H. Buckley, PhD

University of Pennsylvania Perelman School of Medicine, Philadelphia | USA

Lin Y. Hung, PhD

New York University | USA
 

Gastroenterology

Corey J. Ketchem, MD

University of Pennsylvania, Philadelphia | USA

Rishad Khan, MD

University of Toronto | Canada
 

Gastro Hep Advances

Sasha Kapil, MD

UT Southwestern Medical Center, Dallas | USA

June Tome, MD

Mayo Clinic, Rochester, Minnesota | USA
 

Techniques and Innovations in Gastrointestinal Endoscopy

Thomas Enke, MD

University of Colorado, Aurora | USA

Sami Elamin, MD

Harvard, Beth Israel Deaconess Medical Center, Boston | USA

The AGA editorial fellowship program, currently in its seventh year, selects several outstanding individuals who are interested in scientific publishing to take part in the year-long program. We are excited to announce the 2024-25 participants, who will gain hands-on experience and mentorship working closely with the editors and staff at the AGA journals over the next year.

The 10 editorial fellows (2 per journal) will learn about the entire editorial process, from manuscript submission to peer review to acceptance. They will participate in discussions and conferences with the boards of editors, assist with manuscript review, and help disseminate articles via their social media platforms.

AGA

Clinical Gastroenterology and Hepatology

Robyn Jordan, MD, MPH

Johns Hopkins Hospital, Baltimore | USA

Daryl Ramai, MD, MPH, MSc

Brigham and Women’s Hospital, Boston | USA
 

Cellular and Molecular Gastroenterology and Hepatology

Kole H. Buckley, PhD

University of Pennsylvania Perelman School of Medicine, Philadelphia | USA

Lin Y. Hung, PhD

New York University | USA
 

Gastroenterology

Corey J. Ketchem, MD

University of Pennsylvania, Philadelphia | USA

Rishad Khan, MD

University of Toronto | Canada
 

Gastro Hep Advances

Sasha Kapil, MD

UT Southwestern Medical Center, Dallas | USA

June Tome, MD

Mayo Clinic, Rochester, Minnesota | USA
 

Techniques and Innovations in Gastrointestinal Endoscopy

Thomas Enke, MD

University of Colorado, Aurora | USA

Sami Elamin, MD

Harvard, Beth Israel Deaconess Medical Center, Boston | USA

As an AGA member, you can help fund discoveries that will continue to improve GI practice and better patient care.

The AGA Research Foundation has helped make significant strides in advancing the treatment and cure of digestive diseases by funding talented investigators.

Planning your gift to benefit AGA Research Foundation in the future is an opportunity to express what matters to you. As an AGA member, you can work with the AGA Research Foundation to ensure that your planned gift is designated for a purpose that meets your goals for leaving a legacy—such as research awards, support for specific programs, or unrestricted gifts to help meet the Foundation’s mission.

In as little as one sentence in your will and/or trust, you can complete your gift: “I give to AGA Research Foundation, a nonprofit corporation currently located at 4930 Del Ray Avenue, Bethesda, MD 20814, or its successor thereto, _________ [written amount or percentage of the estate or description of property] for its unrestricted charitable use and purpose.”

If you have named the AGA Research Foundation in your will or trust, please let us know so we can ensure that your gift is used according to your wishes. Notifying us of your plans will enable us to plan for the use of your future gift. However, if you prefer to remain anonymous, we will keep your name and gift in strict confidence.

Please contact foundation@gastro.org for more information. If you are considering a planned gift, consult with your own legal and tax advisors.

As an AGA member, you can help fund discoveries that will continue to improve GI practice and better patient care.

The AGA Research Foundation has helped make significant strides in advancing the treatment and cure of digestive diseases by funding talented investigators.

Planning your gift to benefit AGA Research Foundation in the future is an opportunity to express what matters to you. As an AGA member, you can work with the AGA Research Foundation to ensure that your planned gift is designated for a purpose that meets your goals for leaving a legacy—such as research awards, support for specific programs, or unrestricted gifts to help meet the Foundation’s mission.

In as little as one sentence in your will and/or trust, you can complete your gift: “I give to AGA Research Foundation, a nonprofit corporation currently located at 4930 Del Ray Avenue, Bethesda, MD 20814, or its successor thereto, _________ [written amount or percentage of the estate or description of property] for its unrestricted charitable use and purpose.”

If you have named the AGA Research Foundation in your will or trust, please let us know so we can ensure that your gift is used according to your wishes. Notifying us of your plans will enable us to plan for the use of your future gift. However, if you prefer to remain anonymous, we will keep your name and gift in strict confidence.

Please contact foundation@gastro.org for more information. If you are considering a planned gift, consult with your own legal and tax advisors.

As an AGA member, you can help fund discoveries that will continue to improve GI practice and better patient care.

The AGA Research Foundation has helped make significant strides in advancing the treatment and cure of digestive diseases by funding talented investigators.

Planning your gift to benefit AGA Research Foundation in the future is an opportunity to express what matters to you. As an AGA member, you can work with the AGA Research Foundation to ensure that your planned gift is designated for a purpose that meets your goals for leaving a legacy—such as research awards, support for specific programs, or unrestricted gifts to help meet the Foundation’s mission.

In as little as one sentence in your will and/or trust, you can complete your gift: “I give to AGA Research Foundation, a nonprofit corporation currently located at 4930 Del Ray Avenue, Bethesda, MD 20814, or its successor thereto, _________ [written amount or percentage of the estate or description of property] for its unrestricted charitable use and purpose.”

If you have named the AGA Research Foundation in your will or trust, please let us know so we can ensure that your gift is used according to your wishes. Notifying us of your plans will enable us to plan for the use of your future gift. However, if you prefer to remain anonymous, we will keep your name and gift in strict confidence.

Please contact foundation@gastro.org for more information. If you are considering a planned gift, consult with your own legal and tax advisors.

The AGA Research Foundation provides a key source of funding at a critical juncture in a young researcher’s career. By joining others in donating to the AGA Research Foundation, you will ensure that researchers have opportunities to continue their lifesaving work.

The AGA Research Foundation remains committed to providing young researchers with unprecedented research opportunities. Each year, we receive a caliber of nominations for AGA research awards. You can help gifted investigators as they work to advance the understanding of digestive diseases through their novel research objectives.

As an AGA member, you can help fund discoveries that will continue to improve GI practice and better patient care.

AGA grants have led to discoveries, including new approaches to down-regulate intestinal inflammation, a test for genetic predisposition to colon cancer and autoimmune liver disease treatments. The importance of these awards is evidenced by the fact that virtually every major advance leading to the understanding, prevention, treatment, and cure of digestive diseases has been made in the research laboratory of a talented young investigator.

Donate to the AGA Research Foundation to ensure that researchers have opportunities to continue their lifesaving work.

Three Easy Ways To Give

Online: Donate at www.foundation.gastro.org.

Through the mail:

AGA Research Foundation

4930 Del Ray Avenue

Bethesda, MD 20814

Over the phone: 301-222-4002

All gifts are tax-deductible to the fullest extent of U.S. law.






 

The AGA Research Foundation provides a key source of funding at a critical juncture in a young researcher’s career. By joining others in donating to the AGA Research Foundation, you will ensure that researchers have opportunities to continue their lifesaving work.

The AGA Research Foundation remains committed to providing young researchers with unprecedented research opportunities. Each year, we receive a caliber of nominations for AGA research awards. You can help gifted investigators as they work to advance the understanding of digestive diseases through their novel research objectives.

As an AGA member, you can help fund discoveries that will continue to improve GI practice and better patient care.

AGA grants have led to discoveries, including new approaches to down-regulate intestinal inflammation, a test for genetic predisposition to colon cancer and autoimmune liver disease treatments. The importance of these awards is evidenced by the fact that virtually every major advance leading to the understanding, prevention, treatment, and cure of digestive diseases has been made in the research laboratory of a talented young investigator.

Donate to the AGA Research Foundation to ensure that researchers have opportunities to continue their lifesaving work.

Three Easy Ways To Give

Online: Donate at www.foundation.gastro.org.

Through the mail:

AGA Research Foundation

4930 Del Ray Avenue

Bethesda, MD 20814

Over the phone: 301-222-4002

All gifts are tax-deductible to the fullest extent of U.S. law.






 

The AGA Research Foundation provides a key source of funding at a critical juncture in a young researcher’s career. By joining others in donating to the AGA Research Foundation, you will ensure that researchers have opportunities to continue their lifesaving work.

The AGA Research Foundation remains committed to providing young researchers with unprecedented research opportunities. Each year, we receive a caliber of nominations for AGA research awards. You can help gifted investigators as they work to advance the understanding of digestive diseases through their novel research objectives.

As an AGA member, you can help fund discoveries that will continue to improve GI practice and better patient care.

AGA grants have led to discoveries, including new approaches to down-regulate intestinal inflammation, a test for genetic predisposition to colon cancer and autoimmune liver disease treatments. The importance of these awards is evidenced by the fact that virtually every major advance leading to the understanding, prevention, treatment, and cure of digestive diseases has been made in the research laboratory of a talented young investigator.

Donate to the AGA Research Foundation to ensure that researchers have opportunities to continue their lifesaving work.

Three Easy Ways To Give

Online: Donate at www.foundation.gastro.org.

Through the mail:

AGA Research Foundation

4930 Del Ray Avenue

Bethesda, MD 20814

Over the phone: 301-222-4002

All gifts are tax-deductible to the fullest extent of U.S. law.